Abstract| Volume 13, ISSUE 3, e11, May 2019

Predicting Cardiovascular Disease in Familial Hypercholesterolemia: Risk Factors Counting

      A.B. received research grants from Merck Frosst, Amgen, Sanofi, Astra Zeneca and the Fondation Leducq. He has participated in clinical research protocols from Pfizer, Regeneron Pharmaceuticals Inc., The Medecines Company, Amgen, Acasti Pharma Inc., Novartis, Sanofi, Ionis Pharmaceuticals, Inc., Astra Zeneca, Akcea and Merck Frosst. He has served on advisory boards and received honoraria for symposia from Amgen, Akcea and Sanofi.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Clinical Lipidology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect